Summary

The global Sexually Transmitted Diseases (STDs) Testing Devices market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Sexually Transmitted Diseases (STDs) Testing Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Sexually Transmitted Diseases (STDs) Testing Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Sexually Transmitted Diseases (STDs) Testing Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Sexually Transmitted Diseases (STDs) Testing Devices players cover Roche Diagnostics, BioMerieux, Hologic, Inc., Becton Dickinson & Company, Cepheid, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Sexually Transmitted Diseases (STDs) Testing Devices Industry Forecast” looks at past sales and reviews total world Sexually Transmitted Diseases (STDs) Testing Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Sexually Transmitted Diseases (STDs) Testing Devices sales for 2025 through 2031. With Sexually Transmitted Diseases (STDs) Testing Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sexually Transmitted Diseases (STDs) Testing Devices industry.
This Insight Report provides a comprehensive analysis of the global Sexually Transmitted Diseases (STDs) Testing Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sexually Transmitted Diseases (STDs) Testing Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sexually Transmitted Diseases (STDs) Testing Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sexually Transmitted Diseases (STDs) Testing Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sexually Transmitted Diseases (STDs) Testing Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Sexually Transmitted Diseases (STDs) Testing Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Thermal Cyclers
Lateral Flow Readers
Flow Cytometers
Differential Light Scattering Machines
Others
Segmentation by Application:
Laboratory Testing
Point of Care Testing
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
BioMerieux
Hologic, Inc.
Becton Dickinson & Company
Cepheid, Inc.
Danaher Corporation
Affymetrix, Inc.
Alere, Inc.
Abbott Laboratories
DiaSorin
Key Questions Addressed in this Report
What is the 10-year outlook for the global Sexually Transmitted Diseases (STDs) Testing Devices market?
What factors are driving Sexually Transmitted Diseases (STDs) Testing Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sexually Transmitted Diseases (STDs) Testing Devices market opportunities vary by end market size?
How does Sexually Transmitted Diseases (STDs) Testing Devices break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Sexually Transmitted Diseases (STDs) Testing Devices by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Sexually Transmitted Diseases (STDs) Testing Devices by Country/Region, 2020, 2024 & 2031
2.2 Sexually Transmitted Diseases (STDs) Testing Devices Segment by Type
2.2.1 Thermal Cyclers
2.2.2 Lateral Flow Readers
2.2.3 Flow Cytometers
2.2.4 Differential Light Scattering Machines
2.2.5 Others
2.3 Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type
2.3.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Market Share by Type (2020-2025)
2.3.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue and Market Share by Type (2020-2025)
2.3.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sale Price by Type (2020-2025)
2.4 Sexually Transmitted Diseases (STDs) Testing Devices Segment by Application
2.4.1 Laboratory Testing
2.4.2 Point of Care Testing
2.5 Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application
2.5.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sale Market Share by Application (2020-2025)
2.5.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue and Market Share by Application (2020-2025)
2.5.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Breakdown Data by Company
3.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Sales by Company (2020-2025)
3.1.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Market Share by Company (2020-2025)
3.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Revenue by Company (2020-2025)
3.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Company (2020-2025)
3.2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue Market Share by Company (2020-2025)
3.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sale Price by Company
3.4 Key Manufacturers Sexually Transmitted Diseases (STDs) Testing Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sexually Transmitted Diseases (STDs) Testing Devices Product Location Distribution
3.4.2 Players Sexually Transmitted Diseases (STDs) Testing Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Sexually Transmitted Diseases (STDs) Testing Devices by Geographic Region
4.1 World Historic Sexually Transmitted Diseases (STDs) Testing Devices Market Size by Geographic Region (2020-2025)
4.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Sexually Transmitted Diseases (STDs) Testing Devices Market Size by Country/Region (2020-2025)
4.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Sales by Country/Region (2020-2025)
4.2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales Growth
4.4 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales Growth
4.5 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales Growth
4.6 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales Growth
5 Americas
5.1 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country
5.1.1 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country (2020-2025)
5.1.2 Americas Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Country (2020-2025)
5.2 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2025)
5.3 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales by Region
6.1.1 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales by Region (2020-2025)
6.1.2 APAC Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Region (2020-2025)
6.2 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2025)
6.3 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sexually Transmitted Diseases (STDs) Testing Devices by Country
7.1.1 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country (2020-2025)
7.1.2 Europe Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Country (2020-2025)
7.2 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2025)
7.3 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices by Country
8.1.1 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country (2020-2025)
8.1.2 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Country (2020-2025)
8.2 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2025)
8.3 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sexually Transmitted Diseases (STDs) Testing Devices
10.3 Manufacturing Process Analysis of Sexually Transmitted Diseases (STDs) Testing Devices
10.4 Industry Chain Structure of Sexually Transmitted Diseases (STDs) Testing Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sexually Transmitted Diseases (STDs) Testing Devices Distributors
11.3 Sexually Transmitted Diseases (STDs) Testing Devices Customer
12 World Forecast Review for Sexually Transmitted Diseases (STDs) Testing Devices by Geographic Region
12.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Market Size Forecast by Region
12.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Forecast by Region (2026-2031)
12.1.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Sexually Transmitted Diseases (STDs) Testing Devices Forecast by Type (2026-2031)
12.7 Global Sexually Transmitted Diseases (STDs) Testing Devices Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Information
13.1.2 Roche Diagnostics Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications
13.1.3 Roche Diagnostics Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roche Diagnostics Main Business Overview
13.1.5 Roche Diagnostics Latest Developments
13.2 BioMerieux
13.2.1 BioMerieux Company Information
13.2.2 BioMerieux Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications
13.2.3 BioMerieux Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 BioMerieux Main Business Overview
13.2.5 BioMerieux Latest Developments
13.3 Hologic, Inc.
13.3.1 Hologic, Inc. Company Information
13.3.2 Hologic, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications
13.3.3 Hologic, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Hologic, Inc. Main Business Overview
13.3.5 Hologic, Inc. Latest Developments
13.4 Becton Dickinson & Company
13.4.1 Becton Dickinson & Company Company Information
13.4.2 Becton Dickinson & Company Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications
13.4.3 Becton Dickinson & Company Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Becton Dickinson & Company Main Business Overview
13.4.5 Becton Dickinson & Company Latest Developments
13.5 Cepheid, Inc.
13.5.1 Cepheid, Inc. Company Information
13.5.2 Cepheid, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications
13.5.3 Cepheid, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Cepheid, Inc. Main Business Overview
13.5.5 Cepheid, Inc. Latest Developments
13.6 Danaher Corporation
13.6.1 Danaher Corporation Company Information
13.6.2 Danaher Corporation Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications
13.6.3 Danaher Corporation Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Danaher Corporation Main Business Overview
13.6.5 Danaher Corporation Latest Developments
13.7 Affymetrix, Inc.
13.7.1 Affymetrix, Inc. Company Information
13.7.2 Affymetrix, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications
13.7.3 Affymetrix, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Affymetrix, Inc. Main Business Overview
13.7.5 Affymetrix, Inc. Latest Developments
13.8 Alere, Inc.
13.8.1 Alere, Inc. Company Information
13.8.2 Alere, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications
13.8.3 Alere, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Alere, Inc. Main Business Overview
13.8.5 Alere, Inc. Latest Developments
13.9 Abbott Laboratories
13.9.1 Abbott Laboratories Company Information
13.9.2 Abbott Laboratories Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications
13.9.3 Abbott Laboratories Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Abbott Laboratories Main Business Overview
13.9.5 Abbott Laboratories Latest Developments
13.10 DiaSorin
13.10.1 DiaSorin Company Information
13.10.2 DiaSorin Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications
13.10.3 DiaSorin Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 DiaSorin Main Business Overview
13.10.5 DiaSorin Latest Developments
14 Research Findings and Conclusion